Examine the Psychosocial Impacts of COVID-19 Pandemic.

NCT05052333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2574

Last updated 2023-12-06

No results posted yet for this study

Summary

This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and a novel pandemic-related stress (COVID Psychosocial Impacts Scale). Data was collected employing either a unilingual (in native language) or bilingual online survey (with English as a second language) from participants (N=2574) aged 18 and above using a non-probability convenient sampling. The findings enabled us to examine the psychosocial impacts of COVID-19, validate the translations of the CPIS and standardized measures; and determine the trajectory of study variables with pandemic exposure.

Conditions

  • Psychosocial Impacts
  • COVID-19 Pandemic

Sponsors & Collaborators

  • International Islamic University, Islamabad

    collaborator OTHER
  • Universitas Ahmad Dahlan

    collaborator OTHER
  • Gadjah Mada University

    collaborator OTHER
  • Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq

    collaborator OTHER
  • Al-Mustansiriyah University

    collaborator OTHER
  • Hasan Kalyoncu University

    collaborator OTHER
  • University of Washington

    collaborator OTHER
  • University of Malaya

    collaborator OTHER
  • University of Social Welfare and Rehabilitation Science

    collaborator OTHER
  • University of Otago

    lead OTHER

Principal Investigators

  • Caroline Bell, MD · University of Otago Christchurch, New Zealand

  • Sandila Tanveer, PhD · University of Otago Christchurch, New Zealand

  • Ruqayya Sulaiman-Hill, PhD · University of Otago Christchurch, New Zealand

  • Richard Porter, MRCPsych · University of Otago Christchurch, New Zealand

  • Joseph Boden, PhD · University of Otago Christchurch, New Zealand

  • Ben Beaglehole, FRANZCP · University of Otago Christchurch, New Zealand

  • Shaystah Dean, PhD · University of Otago Wellington, New Zealand

  • Philip Schluter, PhD · University of Canterbury, New Zealand

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-09-30
Completion
2023-10-31

Countries

  • United States
  • Indonesia
  • Iran
  • Iraq
  • Malaysia
  • Pakistan
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05052333 on ClinicalTrials.gov